Web Analytics

3 Latest Announced Rounds

$2,265.93M Raised in 95 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Kenai Therapeutics

start up
United States - San Diego, California
  • 01/03/2024
  • Series A
  • $28,000,000

Kenai Therapeutics is a biotechnology company pioneering next generation approaches to cure neurological disorders. The Company utilizes allogeneic induced pluripotent stem cell (iPSC) technology, a Nobel Prize-winning breakthrough that enables scientists to manufacture many human cell types, in order to advance Kenai’s off-the-shelf neuron replacement therapeutics. By focusing on an iPSC technology platform, and forging partnerships with global leaders in surgical delivery and clinical development, Kenai is dedicated to advancing a best-in-class pipeline targeting neurological diseases.


Related People

Howard FederoffCo Founder

Howard Federoff United States - Miami, Florida

Experienced Senior Executive and CEO with a demonstrated history of working in the higher education and biotech industries. Skilled in leading complex organizations, philanthropy and driving excellence, academic and clinical by empowering great teams.
MD, PhD Albert Einstein College of Medicine
Board Certified Internal Medicine, Endocrinology and Metabolism
Expertise in gene therapy, biomarkers, systems medicine and advanced biologics for Parkinson's disease.